Dr. Lukas describes the therapeutic management of glioblastomas.
Standard of Care & Future Directions in the Management of Infiltrating Gliomas
Dr Rimas V. Lukas has reported the following commercial interests:
Personal compensation for consulting, serving on a scientific advisory board, speaking,
or other activities with AbbVie, NewLink Genetics, ReNeuron, Monteris, and the American Physician
Institute; Personal compensation in an editorial capacity for Medlink Neurology and EBSCO.
Honoraria for developing and presenting CME board review content for American